Literature DB >> 9211863

Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades.

J Deprez1, D Vertommen, D R Alessi, L Hue, M H Rider.   

Abstract

To understand the insulin-induced activation of 6-phosphofructo-2-kinase (PFK-2) of the bifunctional enzyme PFK-2/fructose-2,6-bisphosphatase in heart, the effect of phosphorylation by protein kinases of the insulin signaling pathways on PFK-2 activity was studied. Purified PFK-2/fructose-2, 6-bisphosphatase from bovine heart is a mixture of two isoforms (Mr 58,000 and 54,000 on SDS-polyacrylamide gels). The Mr 54,000 protein is an alternatively spliced form, lacking phosphorylation sites for protein kinases. Recombinant enzymes corresponding to the Mr 58,000 (BH1) and Mr 54,000 (BH3) forms were expressed and used as substrates for phosphorylation. The recombinant BH1 isoform was phosphorylated by p70 ribosomal S6 kinase (p70(s6k)), mitogen-activated protein kinase-activated protein kinase-1, and protein kinase B (PKB), whereas the recombinant BH3 isoform was a poor substrate for these protein kinases. Treatment with all protein kinases activated PFK-2 in the recombinant BH1 preparation. Phosphorylation of the recombinant BH1 isoform correlated with PFK-2 activation and was reversed by treatment with protein phosphatase 2A. All the protein kinases phosphorylated Ser-466 and Ser-483 in the BH1 isoform, but to different extents: p70(s6k) preferentially phosphorylated Ser-466, whereas mitogen-activated protein kinase-activated protein kinase-1 and PKB phosphorylated Ser-466 and Ser-483 to a similar extent. We propose that PKB is part of the insulin signaling cascade for PFK-2 activation in heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211863     DOI: 10.1074/jbc.272.28.17269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  139 in total

Review 1.  Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT).

Authors:  G J Kops; B M Burgering
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

Review 2.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  Signaling in control of cell growth and metabolism.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

Review 4.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

Review 5.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 6.  The survival kinases Akt and Pim as potential pharmacological targets.

Authors:  Ravi Amaravadi; Craig B Thompson
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

7.  HER2 Signaling in Breast Cancer.

Authors:  Incheol Shin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  mTORC2 in the center of cancer metabolic reprogramming.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Trends Endocrinol Metab       Date:  2014-05-21       Impact factor: 12.015

9.  Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt.

Authors:  T Kitamura; Y Kitamura; S Kuroda; Y Hino; M Ando; K Kotani; H Konishi; H Matsuzaki; U Kikkawa; W Ogawa; M Kasuga
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

10.  PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.

Authors:  Bradley A Zinker; Cristina M Rondinone; James M Trevillyan; Rebecca J Gum; Jill E Clampit; Jeffrey F Waring; Nancy Xie; Denise Wilcox; Peer Jacobson; Leigh Frost; Paul E Kroeger; Regina M Reilly; Sandra Koterski; Terry J Opgenorth; Roger G Ulrich; Seth Crosby; Madeline Butler; Susan F Murray; Robert A McKay; Sanjay Bhanot; Brett P Monia; Michael R Jirousek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.